Nav: Home

Current Hepatitis News and Events | Page 25

Current Hepatitis News and Events, Hepatitis News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
HIV positive and HIV negative patients have similar survival rates following liver transplant
HIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark. (2009-04-24)
Biolex presents Locteron US Phase 2a hepatitis C data at EASL
Interferon alpha is expected to remain the backbone of hepatitis C treatment, yet there are major issues with current formulations, including frequency of dosing and side effects that impact compliance. (2009-04-24)
First evidence for DNA-based vaccination against chronic hepatitis C
The first proof of concept for a DNA-based therapeutic vaccination against chronic hepatitis C was announced today at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark. (2009-04-23)
Diabetes, obesity and hypertension increase mortality in hepatitis C patients
The specific impact of metabolic syndrome on mortality in hepatitis C patients has been revealed by new research to be presented on Sunday April 26 at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark. (2009-04-22)
Do patients at risk for B-cell malignancy need antiviral treatment?
The association of hepatitis C infection with type II mixed cryoglobulinemia is well established, but the role of HCV in B-cell lymphoma remains controversial. (2009-04-15)
Shared equipment can lead to hepatitis B outbreaks
Patient-to-patient transmission of hepatitis B virus can occur as the result of routine clinical practices incorrectly thought to be risk-free. (2009-04-08)
The immune system's role in hepatitis C recurrence after liver transplantation
A new study pinpoints certain aspects of the immune system that may play a role in the recurrence and progression of hepatitis C virus after liver transplantation. (2009-04-01)
New studies examine elimination of hepatitis B and C
Two new studies in the April issue of Hepatology explore the ways that hepatitis B virus and hepatitis C virus can be cleared from patients' bodies. (2009-04-01)
Mutations within a conservative region of HCV affects the therapy
A research group from Egypt investigated the relationship between mutations within a conservative region of the hepatitis C virus (HCV) genome and response to therapy. (2009-03-30)
New link in liver cancer
Liver damage can be triggered by various insults, including hepatitis infection or alcohol-induced cirrhosis. (2009-03-30)
Redefining DNA: Darwin from the atom up
In a dramatic rewrite of the recipe for life, scientists from Florida describe the design of a new type of DNA with 12 chemical letters instead of the usual four. (2009-03-23)
Study identifies human genes required for hepatitis C viral replication
Massachusetts General Hospital researchers are investigating a new way to block reproduction of the hepatitis C virus -- targeting not the virus itself but the human genes the virus exploits in its life cycle. (2009-03-18)
Scripps research team identifies key molecules that inhibit viral production
A team from the Scripps Research Institute has found a way to inhibit viral production of the hepatitis C virus. (2009-03-10)
Varicella zoster infection causes severe autoimmune hepatitis
Autoimmune hepatitis (AIH) is a chronic disease of unknown etiology that is characterized by the presence of circulatory autoantibodies and inflammatory histological changes in the liver. (2009-03-03)
Liver transplant recipients with hepatitis B may need lifelong antiviral treatment
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back. (2009-02-26)
Liver tumors associated with metabolic syndrome differ from other tumors
A new study suggests that the metabolic response to obesity and insulin resistance, particularly as it pertains to the liver, differs among ethnic groups in the US African-Americans are more resistant to the buildup of fat in the abdominal adipose tissue and liver, and to high triglyceride levels associated with insulin resistance. (2009-02-25)
New analysis shows liver cancer incidence has tripled since 1970s, but survival rates improving
A summary of a study published online Feb. 17, 2009, in the Journal of Clinical Oncology showed that hepatocellular carcinoma (liver cancer) incidence and mortality have increased substantially in the United States over the past three decades, but survival rates are improving. (2009-02-18)
A potential marker of increased histological activity in hepatitis C virus infection
Lymphocyte proliferative responses specific to hepatitis C virus have been regarded as pivotal for viral clearance, while antibody responses' contribution is still controversial. (2009-02-17)
When acute hepatitis develops into chronic hepatitis
Hepatitis B is the most prevalent infectious disease in the world. (2009-02-16)
What are the histologic features of intrahepatic neonatal cholestasis?
A research group from Brazil compare the histologic features of the liver in intrahepatic neonatal cholestasis (IHNC) with infectious, genetic-endocrine-metabolic, and idiopathic etiologies. (2009-02-14)
Gang researchers at UH examine health, consequences of long-term gang
The University of Houston Center for Drug and Social Policy Research has been awarded a $2.4 million grant by the National Institutes of Health to study the long-term consequences of adolescent gang membership among Mexican Americans. (2009-02-12)
Inflammation may be common thread behind nervous and heart rhythm problems in cirrhosis
Inflammatory molecules known as cytokines can lead to the neurological and cognitive abnormalities and changes in heart rhythm found in patients with cirrhosis of the liver, a new study finds. (2009-02-10)
Novel economical blood test for hepatitis C
A novel blood test could bring a breakthrough in the battle against the dangerous hepatitis-C virus. (2009-02-09)
Oncostatin M may be a promising drug for treating viral hepatitis and liver cancer
The Department of Gene Therapy and Hepatology of the Center for Applied Medical Research of the University of Navarra has identified a molecule as possibly effective for improving the treatment of chronic hepatitis and liver cancer. (2009-02-09)
Hepatitis C is killing liver cells
It has long been thought that liver disease in hepatitis C patients is caused by the patient's immune system attacking the infected liver, ultimately killing the cells. (2009-02-05)
Poor people suffer disproportionately from chronic infections
Kids from low-income families are much more likely to suffer from serious infections such as herpes or hepatitis A than their counterparts in wealthier households. (2009-02-05)
Prestigious fellowship for young Nottingham researcher
A promising young researcher at The University of Nottingham has been awarded a prestigious national fellowship to support her work investigating the molecular biology of hepatitis C virus. (2009-02-03)
Pitt receives $11 million from NIH to coordinate hepatitis B clinical research network
The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a seven-year, $11 million grant to the University of Pittsburgh Graduate School of Public Health to coordinate the Hepatitis B Clinical Research Network -- a consortium of 15 clinical and research centers in the US and Canada that will conduct translational research on hepatitis B. (2009-01-29)
Discovery could lead to a new animal model for hepatitis C
The hepatitis C virus is interested in only one thing: human liver cells. (2009-01-28)
Universal infant hepatitis B immunization recommended
All countries should offer universal infant immunization for hepatitis B, write Dr. (2009-01-19)
Clinical features of hepatocellular carcinoma associated with autoimmune liver disease
A research group from Japan characterized the clinical features of hepatocellular carcinoma (HCC) associated with autoimmune liver disease. (2009-01-18)
Hepatitis C may increase pancreatic cancer risk
A new study shows that infection with hepatitis C virus increases a person's risk for a highly fatal cancer of the biliary tree, the bile carrying pathway between the liver and pancreas. (2009-01-13)
Annals of Internal Medicine tip sheet for Jan. 6, 2009, issue
Below is information about three studies being published in the Jan. (2009-01-05)
A new light on the anti-tumor mechanisms of Scutellaria barbata
A research group in China investigated the growth inhibitory and apoptotic effects of Scutellaria barbata D.Don (S. barbata) and determined the underlying mechanism of its anti-tumor activity in mouse liver cancer cell line H22. (2008-12-31)
A rigorous method for liver biopsy
A research group from Italy describes a rigorous method based on the fundamentals of measurement theory, which metrically defines the changes of magnitude of liver tissue prime basic structural elements occurring during the course of B and C chronic hepatitis. (2008-12-31)
May hepatic granulomas be part of the histological spectrum of chronic hepatitis C?
Granulomas are sometimes found in the livers of patients with abnormal liver tests, and this can trigger an exhaustive search for the cause. (2008-12-29)
Needle/syringe programs and opioid substitution therapy should be widely available in prisons
Prisons should have needle and syringe programs, opioid substitution therapy and other preventive measures in place to prevent HIV transmission between inmates. (2008-12-23)
Using math to understand hep. C: Patterns paint picture of who will respond to treatment
New research findings show doctors how to predict whether or not a patient with hepatitis C will respond to traditional therapy. (2008-12-22)
How to tell if a hepatitis-C-virus-infected patient will respond to therapy
Hepatitis C virus (HCV) causes hepatitis and liver cancer. Current treatments are expensive, have severe side effects, and fail in about half the patient. (2008-12-22)
Hepatitis C treatment reduces the virus but liver damage continues
Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study finds. (2008-12-09)
Page 25 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...